Fresenius Medical Care AG (ETR:FME – Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of €38.78 ($39.98) and traded as high as €44.82 ($46.21). Fresenius Medical Care shares last traded at €44.82 ($46.21), with a volume of 424,076 shares.
Fresenius Medical Care Stock Performance
The company has a debt-to-equity ratio of 77.56, a quick ratio of 0.80 and a current ratio of 1.46. The firm has a 50 day moving average of €43.40 and a two-hundred day moving average of €38.78. The stock has a market cap of $13.17 billion, a P/E ratio of 24.81, a P/E/G ratio of 0.42 and a beta of 0.86.
Fresenius Medical Care Company Profile
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Read More
- Five stocks we like better than Fresenius Medical Care
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- Low PE Growth Stocks: Unlocking Investment Opportunities
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- What is Forex and How Does it Work?
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.
